To identify drug targets for ARID1A-mutant cancer cells, we analyzed the publicly available GDSC drug database [32] and compared the drug sensitivities of ARID1A-mutant and ARID1A-wildtype cancer cell lines. Here, ARID1A is linked to cancer.